Anticoagulant drugs increase natural killer cell activity in lung cancer

This publication has 29 references indexed in Scilit:

• Low-Molecular-Weight Heparin and Dermatan Sulfate End Group-Labeled with Tyramine and Fluorescein. Biochemical and Biological Characterization of the Fluorescent-Labeled Heparin Derivative
  Seminars in Thrombosis and Hemostasis, 2002
• Efficacy of Low-Molecular-Weight Heparin and Unf ractionated Heparin to Prevent Adhesion of Human Prostate and Bladder Carcinoma and Melanoma Cells to Bovine Endothelial Monolayers
  Urologia Internationalis, 1996
• Basic-Fibroblast-Growth-Factor-Mediated de novo Angiogenesis Is More Effectively Suppressed by Low-Molecular-Weight than by High-Molecular-Weight Heparin
  International Journal of Microcirculation, 1996
• Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity
  Nature, 1994
• Variations in the Size and Sulfation of Heparin Modulate the Effect of Heparin on the Binding of VEGF165 to Its Receptors
  Biochemical and Biophysical Research Communications, 1994
• Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis
  The Lancet, 1992
• Augmentation of Antimetastatic Activity of Interferon and Tumor Necrosis Factor by Heparin
  Immunopharmacology and Immunotoxicology, 1990
• Role of nk cells in the antimetastatic effect of anticoagulant drugs
  International Journal of Cancer, 1984
• The effect of coumarin derivatives on the immunological system of man
  Inflammation Research, 1983
• Role of NK cells in the control of metastatic spread and growth of tumor cells in mice
  International Journal of Cancer, 1982